
Modern Diagnostic IPO Subscription Day 1
Posted by : sachet | Wed Dec 31 2025

Here, the Modern Diagnostic IPO launched on 31st December 2025. Bidding for the issue will close today, 7th January 2026. The primary aim of the Modern Diagnostic IPO is to raise ₹36.89 crores from the market. Also, the Modern Diagnostic IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Modern Diagnostic IPO subscription and details.
Modern Diagnostic IPO Details
| IPO Open Date | 31st December 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹85 to ₹90 per share |
| Lot Size | 1,600 Shares |
| Issue Type | Bookbuilding Issue |
| Listing At | BSE & SME |
| IPO Close Date | 2nd January 2026 |
| Listing Date | 7th January 2026 |
The price band for Riddhi Display Equipment’s IPO has been set at ₹85 to ₹90 per share, and a total of 40,99,200 shares are being issued. Let’s segregate the share quota fixed for different categories of investors.
| Investor Categories | Shares Offered | Shares Percentage |
| Market Maker Shares Offered | 2,06,400 | 5.04% |
| QIB shares offered | 19,44,000 | 47.42% |
| NII (HNI) Shares Offered | 5,85,600 | 14.29% |
| Retail Shares Offered | 13,63,200 | 33.26% |
| Total Shares Offered | 40,99,200 | 100.00% |
Modern Diagnostic IPO Subscription Status
As of now, the Modern Diagnostic IPO has been subscribed to 0.80 times. Of these, 0.96 times are subscribed by retail investors, 1.50 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of Modern Diagnostic’s IPO listing on 7th January 2026. Modern Diagnostic also has a positive outlook behind the fresh issue of 0.41 crore shares, which will raise around Rs 36.89 crores.
Modern Diagnostic IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Modern Diagnostic IPO GMP for 31st December 2025.
The grey market premium for this IPO has surged to 11.11% or Rs 10.00 per share. It indicates that the estimated listing price per share is Rs 100.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 31-12-2025 | ₹90 | ₹10 | ₹100 | 11.11% |
| 30-12-2025 | ₹90 | ₹10 | ₹100 | 11.11% |
| 29-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 28-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 27-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
| 26-12-2025 | ₹0.00 | ₹0.00 | ₹0.00 | 0.00% |
About Modern Diagnostic Ltd.
Modern Diagnostic & Research Centre was established in 1985. Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services. The company provides reliable diagnostic tests, home specimen collection, online reports, and customised test packages for institutional customers and patients, tailored to their specific needs. The company operates 21 centres (18 labs, three diagnostic centres) across eight states, offering diagnostic services such as ultrasound, CT, MRI, X-ray, ECG, PFT, and specialised labs for heart and neuro care. The company has been providing services such as Pathology, Radiology and Home sample collection.
Modern Diagnostic Limited Financials
The company’s financial analysis is essential before applying for the Modern Diagnostic IPO. Look at the table to learn about Modern Diagnostic Limited’s financials.
| Year Ended | 30th June 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 77.86 | 64.57 | 49.49 | 36.54 |
| Revenue | 22.67 | 78.80 | 68.67 | 56.61 |
| Profit After Tax | 3.00 | 8.97 | 5.79 | -5.73 |
| EBITDA | 5.86 | 17.96 | 11.05 | -0.99 |
| Net Worth | 23.72 | 20.73 | 11.76 | 5.96 |
| Reserves and Surplus | 12.72 | 9.73 | 10.76 | 4.96 |
| Total Borrowings | 30.38 | 22.09 | 20.46 | 15.31 |
Explanation
Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.
Technical Indicators
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Modern Diagnostic IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 11.04 |
| EPS (Earnings Per Share) | 8.15 |
| RoNW | 43.27% |
| ROCE | 36.18% |
| ROE | 55.21% |
| EBITDA Margin | 23.04% |
| Price to Book Value | 4.78 |
| Market Capitalisation | ₹135.89 Cr |
Modern Diagnostic IPO Listing Expectations
Modern Diagnostic IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 11.11% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 100.
It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation.
Modern Diagnostic IPO Dates
| IPO Open Date | 31st December 2025 |
| IPO Close Date | 2nd January 2026 |
| Allotment | 5th January 2026 |
| Refund Date | 6th January 2026 |
| IPO Listing Date | 7th January 2026 |
Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Modern Diagnostic IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

